Skin care brand Cannuka only came to market towards the end of last year, and already the company has received $750,000 in funding and seen 70 percent month-to-month growth in sales.
What’s the secret ingredient behind its success? Cannabis.
The brand’s products consist of a combination of CBD oils and manuka honey.
“CBD...is a very powerful anti-inflammatory...But we knew we needed to complement that with another ingredient,” explained Cannuka's Founder and CEO, Michael Bumgarner. “That’s when we found manuka honey, [which] is the most powerful antibacterial honey in the world.”
On top of the ingredients, Cannuka’s branding was designed to appeal to a wider market.
“We knew because we’re in the cannabis space we had to be approachable,” said Bumgarner. “It’s harder to explain the benefits because you have that stigma still about it.”
So far, Cannuka has been selling direct-to-consumer through its website but now wants to hit brick-and-mortar stores.
For the full interview, [click here](https://cheddar.com/videos/inside-the-power-of-cbd-for-skincare).
Chris Versace, CIO at Tematica Research and portfolio manager for TheStreet Pro, joins from the NYSE to break down the Fed’s latest move and Big Tech’s earnings
Sabrina Siddiqui, National Politics Reporter at The Wall Street Journal, joins to break down the SNAP funding delays and the human cost of the ongoing shutdown.
AI is reshaping investigations. Longeye CEO Guillaume Delepine shares how their AI workspace empowers law enforcement to uncover insights faster and smarter.
Stephen Kates, Financial Analyst at Bankrate, joins to discuss the Fed’s 25-basis-point rate cut, inflation risks, and what it all means for consumers and marke
Big tech earnings take center stage as investors digest results from Alphabet, Meta, Microsoft, Amazon, and Apple, with insights from Gil Luria of D.A. Davidson
